Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively - PubMed (original) (raw)
. 1996 Mar 15;93(6):1079-82.
doi: 10.1161/01.cir.93.6.1079.
N Horelli-Kuitunen, D Chilov, E Kukk, S Pennanen, O P Kallioniemi, K Pajusola, B Olofsson, U Eriksson, V Joukov, A Palotie, K Alitalo
Affiliations
- PMID: 8653826
- DOI: 10.1161/01.cir.93.6.1079
Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively
K Paavonen et al. Circulation. 1996.
Abstract
Background: Vascular endothelial growth factor (VEGF) is an important regulator of endothelial cell proliferation, migration, and permeability during embryonic vasculogenesis as well as in physiological and pathological angiogenesis. The recently isolated VEGF-B and VEGF-C cDNAs encode novel growth factor genes of the VEGF family.
Methods and results: Southern blotting and polymerase chain reaction analysis of somatic cell hybrids and fluorescence in situ hybridization (FISH) of metaphase chromosomes were used to assess the chromosomal localization of VEGF-B and VEGF-C genes. The VEGF-B gene was found on chromosome 11q13, proximal to the cyclin D1 gene, which is amplified in a number of human carcinomas. However, VEGF-B was not amplified in several mammary carcinoma cell lines containing amplified cyclin D1. The VEGF-C gene was located on chromosome 4q34, close to the human aspartylglucosaminidase gene previously mapped to 4q34-35.
Conclusions: The VEGF-B locus in 11q13 and the VEGF-C locus in 4q34 are candidate targets for mutations that lead to vascular malformations or cardiovascular diseases.
Similar articles
- Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12.
Wei MH, Popescu NC, Lerman MI, Merrill MJ, Zimonjic DB. Wei MH, et al. Hum Genet. 1996 Jun;97(6):794-7. Hum Genet. 1996. PMID: 8641698 - Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.
Vincenti V, Cassano C, Rocchi M, Persico G. Vincenti V, et al. Circulation. 1996 Apr 15;93(8):1493-5. doi: 10.1161/01.cir.93.8.1493. Circulation. 1996. PMID: 8608615 - Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK. Boocock CA, et al. J Natl Cancer Inst. 1995 Apr 5;87(7):506-16. doi: 10.1093/jnci/87.7.506. J Natl Cancer Inst. 1995. PMID: 7707437 - Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.
Yamada Y, Nezu J, Shimane M, Hirata Y. Yamada Y, et al. Genomics. 1997 Jun 15;42(3):483-8. doi: 10.1006/geno.1997.4774. Genomics. 1997. PMID: 9205122 - Signaling pathways induced by vascular endothelial growth factor (review).
Larrivée B, Karsan A. Larrivée B, et al. Int J Mol Med. 2000 May;5(5):447-56. doi: 10.3892/ijmm.5.5.447. Int J Mol Med. 2000. PMID: 10762646 Review.
Cited by
- Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications.
Wazan LE, Widhibrata A, Liu GS. Wazan LE, et al. Angiogenesis. 2024 Nov;27(4):641-661. doi: 10.1007/s10456-024-09942-8. Epub 2024 Aug 29. Angiogenesis. 2024. PMID: 39207600 Review. - The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors.
Wasik A, Ratajczak-Wielgomas K, Badzinski A, Dziegiel P, Podhorska-Okolow M. Wasik A, et al. Cancers (Basel). 2022 Aug 30;14(17):4225. doi: 10.3390/cancers14174225. Cancers (Basel). 2022. PMID: 36077762 Free PMC article. Review. - Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma.
Nasry WHS, Martin CK. Nasry WHS, et al. Front Oncol. 2021 May 21;11:539361. doi: 10.3389/fonc.2021.539361. eCollection 2021. Front Oncol. 2021. PMID: 34094895 Free PMC article. Review. - Structural Studies on an Anti-Angiogenic Peptide Using Molecular Modeling.
Assareh E, Mehrnejad F, Asghari SM. Assareh E, et al. Iran J Biotechnol. 2020 Oct 1;18(4):e2553. doi: 10.30498/IJB.2020.2553. eCollection 2020 Oct. Iran J Biotechnol. 2020. PMID: 34056022 Free PMC article. - Resistance Mechanisms to Anti-angiogenic Therapies in Cancer.
Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, Shamseddine A. Haibe Y, et al. Front Oncol. 2020 Feb 27;10:221. doi: 10.3389/fonc.2020.00221. eCollection 2020. Front Oncol. 2020. PMID: 32175278 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials